Detalhe da pesquisa
1.
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
N Engl J Med
; 382(24): 2289-2301, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32521132
2.
Maternal and fetal outcomes in acute hepatic porphyria: A Swedish National Cohort Study.
J Inherit Metab Dis
; 46(4): 675-686, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078226
3.
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals.
J Inherit Metab Dis
; 46(2): 286-299, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546345
4.
Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.
J Inherit Metab Dis
; 46(6): 1186-1194, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650859
5.
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
N Engl J Med
; 380(6): 549-558, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30726693
6.
Acute hepatic porphyria and maternal health: Clinical and biochemical follow-up of 44 pregnancies.
J Intern Med
; 291(1): 81-94, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34411356
7.
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
J Intern Med
; 291(6): 824-836, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112415
8.
Treatment with assisted reproduction technologies in women with acute hepatic porphyria.
Acta Obstet Gynecol Scand
; 100(9): 1712-1721, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060066
9.
Homocysteine elevation in givosiran treatment: Suggested ALAS1 siRNA effect on cystathionine beta-synthase.
J Intern Med
; 290(4): 928-930, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34184789
10.
Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947.
Cancers (Basel)
; 15(3)2023 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765753
11.
Integrating virtual patients into courses: follow-up seminars and perceived benefit.
Med Educ
; 46(4): 417-25, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22429178
12.
A Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver.
Clin Pharmacol Ther
; 110(5): 1250-1260, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34510420
13.
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.
Genome Med
; 13(1): 40, 2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33726816
14.
Challenges in the management of acute intermittent porphyria with recurrent attacks during pregnancy: A case report.
Clin Case Rep
; 8(12): 2483-2487, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33363763
15.
[Hereditary metabolic diseases with onset in adulthood. Early and correct treatment of acute symptoms can be life-saving]. / Ärftliga metabola sjukdomar med symtomdebut i vuxen ålder - Tidig och korrekt behandling vid akuta symtom kan vara livräddande.
Lakartidningen
; 1132016 Feb 01.
Artigo
em Sueco
| MEDLINE | ID: mdl-26835685
16.
Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
Clin Exp Metastasis
; 20(5): 437-44, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14524533
17.
Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Clin Exp Metastasis
; 28(1): 65-73, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20967488